Measuring biological age using omics data J Rutledge, H Oh, T Wyss-Coray Nature Reviews Genetics 23 (12), 715-727, 2022 | 298 | 2022 |
Organ aging signatures in the plasma proteome track health and disease HSH Oh, J Rutledge, D Nachun, R Pálovics, O Abiose, P Moran-Losada, ... Nature 624 (7990), 164-172, 2023 | 189 | 2023 |
CD4+ T cells contribute to neurodegeneration in Lewy body dementia D Gate, E Tapp, O Leventhal, M Shahid, TJ Nonninger, AC Yang, ... Science 374 (6569), 868-874, 2021 | 153 | 2021 |
Cerebrospinal fluid immune dysregulation during healthy brain aging and cognitive impairment N Piehl, L van Olst, A Ramakrishnan, V Teregulova, B Simonton, Z Zhang, ... Cell 185 (26), 5028-5039. e13, 2022 | 100 | 2022 |
Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer’s disease YJ Sung, C Yang, J Norton, M Johnson, A Fagan, RJ Bateman, RJ Perrin, ... Science translational medicine 15 (703), eabq5923, 2023 | 36 | 2023 |
Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and informs causal proteins for Alzheimer’s disease C Cruchaga, D Western, J Timsina, L Wang, C Wang, C Yang, M Ali, ... Research square, 2023 | 29 | 2023 |
Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer’s disease L Wang, NP Nykänen, D Western, P Gorijala, J Timsina, F Li, Z Wang, ... Molecular neurodegeneration 19 (1), 1, 2024 | 16 | 2024 |
Methods to investigate intrathecal adaptive immunity in neurodegeneration H Oh, O Leventhal, D Channappa, VW Henderson, T Wyss-Coray, ... Molecular neurodegeneration 16, 1-11, 2021 | 15 | 2021 |
Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer’s disease. C Cruchaga, M Ali, Y Shen, A Do, L Wang, D Western, M Liu, A Beric, ... Research Square, 2024 | 6 | 2024 |
Disagreement on foundational principles of biological aging VN Gladyshev, B Anderson, H Barlit, B Barré, S Beck, B Behrouz, ... PNAS nexus 3 (12), pgae499, 2024 | 4 | 2024 |
Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease D Western, J Timsina, L Wang, C Wang, C Yang, B Phillips, Y Wang, ... Nature Genetics, 1-13, 2024 | 3 | 2024 |
Synapse protein signatures in cerebrospinal fluid and plasma predict cognitive maintenance versus decline in Alzheimers disease HSH Oh, DY Urey, L Karlsson, Z Zhu, Y Shen, A Farinas, J Timsina, ... bioRxiv, 2024.07. 22.604680, 2024 | 2 | 2024 |
Plasma proteomics in the UK Biobank reveals youthful brains and immune systems promote healthspan and longevity HSH Oh, Y Le Guen, N Rappoport, DY Urey, J Rutledge, A Brunet, ... bioRxiv, 2024.06. 07.597771, 2024 | 2 | 2024 |
Multi‐cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer’s disease M Ali, J Timsina, Y Shen, A Do, L Wang, D Western, E Liu, A Beric, G Heo, ... Alzheimer's & Dementia 20 (Suppl 2), e084185, 2025 | | 2025 |
Integration of GWAS and cerebrospinal fluid proteogenomics identifies proteins for AD and shared dysregulated mechanisms in other neurological traits D Western, C Yang, J Timsina, P Gorijala, M Liu, A Ruiz, M Marquié, ... Alzheimer's & Dementia 20 (Suppl 8), e095164, 2025 | | 2025 |
Changes in cerebrospinal fluid synaptic proteins precede and coincide with Alzheimer’s pathology and govern cognitive function HSH Oh, T Wyss‐Coray Alzheimer's & Dementia 20, e088757, 2024 | | 2024 |
Biological Aging and the Motoric Cognitive Risk Syndrome S Sathyan, HSH Oh, A Emmeline, J Rutledge, D Adhikari, T Gao, ... Alzheimer's & Dementia 20, e089384, 2024 | | 2024 |
Deciphering Human Aging and Neurodegeneration with Large-Scale Fluid Proteomics HSH Oh Stanford University, 2024 | | 2024 |